AWHL · Aspira Women's Health Inc.
$0.26
+0.00 (+0.00%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Given the above conditions, there is substantial doubt about the Company's ability to continue as a going concern within one year after the date these consolidated interim financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$12.12M
Shares
46.63M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Nicole Sandford | Former President, President & Chief Executive Officer | $1,242,280 |
| Sandra Milligan | M.D., J.D. Former President, Interim Chief Executive Officer | $358,429 |
| Torsten Hombeck | Former Chief Financial Officer | $275,204 |
| Minh Merchant | Former General Counsel & Secretary | $159,470 |
| John Kallassy | Former Interim Chief Financial Officer | $85,980 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Nicole Sandford | Former President, President & Chief Executive Officer | $1,035,590 |
| Minh Merchant | Former General Counsel & Secretary | $562,501 |
| Ryan Phan | Chief Scientific and Operating Officer | $532,881 |
| Valerie Palmieri | Former Executive Chair of the Board, President and Chief Executive Officer | $386,264 |
| Torsten Hombeck | Former Chief Financial Officer | $365,662 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Valerie Palmieri | Former Executive Chair of the Board, President and Chief Executive Officer | $653,182 |
| Nicole Sandford | President, Chief Executive Officer | $604,256 |
| Robert Beechey | Former Chief Financial Officer | $478,717 |
| Minh Merchant | General Counsel & Secretary | $459,083 |
| Ryan Phan | Chief Scientific and Operating Officer | $453,564 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Valerie Palmieri | Former Executive Chair of the Board, President and Chief Executive Officer | $2,692,163 |
| Robert Beechey | Former Chief Financial Officer | $1,084,432 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| John Fraser | Interim Chief Executive Officer | Appointed | 2026-06-22 |
| Brian Hungerford | Chief Financial Officer | Terminated | 2026-04-30 |
| John Strahley | Chief Accounting Officer | Appointed | 2026-04-30 |
| John Strahley | Chief Financial Officer | Appointed | 2026-04-30 |
| Brian Hungerford | Principal Accounting Officer | Appointed | 2025-09-03 |
| Brian Hungerford | Chief Financial Officer | Appointed | 2025-09-03 |
| Jane Pine Wood | director | Appointed | 2025-07-15 |
| John Fraser | director | Appointed | 2025-04-08 |
| Cynthia Hundorfean | director | Appointed | 2025-04-08 |
| Julie Carrillo | Principal Accounting Officer | Appointed | 2025-04-08 |
| Jeffrey Cohen, M.D. | director | Appointed | 2025-04-08 |
| Michael Buhle | Chief Executive Officer | Appointed | 2025-03-31 |
| James Crawford | VP of Finance | Resigned | 2025-03-25 |
| Celeste Fralick | director | Resigned | 2025-03-19 |
| Ellen Beausang | director | Appointed | 2025-02-10 |
| Dr. Sandra Milligan | President | Resigned | 2025-02-10 |
| Michael Buhle | Chief Executive Officer | Appointed | 2025-01-31 |
| John Kallassy | Interim Chief Financial Officer | Resigned | 2025-01-07 |
| Sandra Milligan | interim CEO | Appointed | 2024-12-16 |
| John Ragard | director | Appointed | 2024-07-29 |
| Nicole Sandford | interim Chief Financial Officer | Appointed | 2024-06-27 |
| Dr. Torsten Hombeck | Chief Financial Officer | Terminated | 2024-06-27 |
| Torsten Hombeck | Corporate Secretary | Appointed | 2024-06-07 |
| Minh Merchant | General Counsel, Chief Compliance Officer, and Corporate Secretary | Resigned | 2024-04-26 |
| Sandra Milligan, M.D., J.D. | President | Appointed | 2024-03-21 |